Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Depreciation & Amortization (CF) (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Depreciation & Amortization (CF) for 12 consecutive years, with $615000.0 as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 46.8% year-over-year to $615000.0; the TTM value through Mar 2026 reached $2.4 million, up 13.84%, while the annual FY2025 figure was $3.0 million, 157.08% up from the prior year.
  • Depreciation & Amortization (CF) hit $615000.0 in Q1 2026 for Cartesian Therapeutics, up from $608000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.2 million in Q1 2025 and bottomed at $176000.0 in Q2 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $403235.3, with a median of $345000.0 recorded in 2022.
  • Year-over-year, Depreciation & Amortization (CF) tumbled 48.99% in 2023 and then soared 531.69% in 2025.
  • Cartesian Therapeutics' Depreciation & Amortization (CF) stood at $241000.0 in 2022, then increased by 12.86% to $272000.0 in 2023, then skyrocketed by 78.68% to $486000.0 in 2024, then increased by 25.1% to $608000.0 in 2025, then rose by 1.15% to $615000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $615000.0, $608000.0, and $606000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.